Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 10, p. 343, doi. 10.1177/1756285617722706
- By:
- Publication type:
- Article